Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: In a recently completed 3-year, randomized, double-blind study, denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κB ligand, significantly increased bone mineral density and decreased new vertebral fractures in men receiving androgen deprivation thera...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Smith, Matthew R., Saad, Fred, Egerdie, Blair, Szwedowski, Maciej, Tammela, Teuvo L. J., Ke, Chunlei, Leder, Benjamin Z., Goessl, Carsten
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900763/
https://ncbi.nlm.nih.gov/pubmed/19836774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.08.048
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items